BioMarin to Host First Quarter 2021 Financial Results Conference Call and Webcast on Thursday, April 29 at 4:30pm ET

Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will conduct a conference call and webcast on April 29, 2021, at 4:30 p.m. ET to discuss its first quarter 2021 financial results and provide a business update. The call will be hosted by CEO Jean-Jacques Bienaimé. Interested parties can join via the BioMarin website. A replay will also be available for a week after the call. BioMarin specializes in therapies for serious rare genetic diseases, with a portfolio of six commercial products and several candidates in development.

Positive

• Upcoming conference call will provide insights into first quarter 2021 financial results.
• BioMarin's focus on innovative therapies for rare genetic diseases highlights growth potential.

Negative

• None.

SAN RAFAEL, Calif., April 13, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, April 29, at 4:30 p.m. ET to discuss first quarter 2021 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: (866) 502-9859
International Dial-in Number: (574) 990-1362
Conference ID: 2396463

Replay Dial-in Number: (855) 859-2056
Replay International Dial-in Number: (404) 537-3406
Conference ID: 2396463

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-host-first-quarter-2021-financial-results-conference-call-and-webcast-on-thursday-april-29-at-430pm-et-301266955.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is BioMarin's first quarter 2021 financial results conference call?

The conference call is scheduled for April 29, 2021, at 4:30 p.m. ET.

How can I access BioMarin's financial results conference call?

You can access the call via the investor section of BioMarin's website.

What will BioMarin discuss during the conference call?

BioMarin will discuss its first quarter 2021 financial results and provide a general business update.

What is BioMarin's area of focus?

BioMarin develops therapies for patients with serious and life-threatening rare genetic diseases.